1. Introduction
===============

In recent decades, the prevalence of obesity has increased substantially in North America reaching epidemic proportions.^\[[@R1]\]^ It is estimated that over one-third of American adults (36%) are obese and more than two-thirds (69%) are overweight.^\[[@R2]\]^ While there are many parameters describing body weight status, the most popular formula is the Quetelet index, also known as body mass index (BMI).^\[[@R3]\]^ The BMI can be calculated easily and quickly and thus it is widely used both in research and clinical areas. BMI of between 25 and 29.9 is considered as overweight, while BMI of 30 or greater is considered obese based on recent National Institute of Health (NIH) classification.^\[[@R4]\]^ Overweight and obesity have long been considered major risk factors for mortality in the general population. Overweight and obesity are associated with a variety of cardiometabolic diseases, such as type 2 diabetes mellitus, hypertension, hyperlipidemia, metabolic syndrome, cardiovascular disease (CVD), and certain types of cancers,^\[[@R4]\]^ and these conditions in turn contribute to increased mortality.^\[[@R5],[@R6]\]^

Given these associations, we might safely infer that overweight or obese individuals would have more adverse outcomes than healthy weight individuals. Yet, there is increasing evidence that patients, especially elderly with several chronic diseases and elevated BMI, may demonstrate lower all-cause and cardiovascular mortality compared with patients of normal weight. For instance, lower mortality was observed among patients with a BMI range of 20 to 24.9 kg/m^2^ (for nonsmokers in the American and European populations) while mortality increases below and above this range.^\[[@R7]\]^ This unexpected phenomenon has been termed the "obesity paradox," and has also been observed in other diseases such as diabetes,^\[[@R8]--[@R10]\]^ coronary artery disease,^\[[@R11],[@R12]\]^ heart failure,^\[[@R13]\]^ peripheral arterial disease,^\[[@R12]\]^ hypertension,^\[[@R14]\]^ chronic obstructive pulmonary disease (COPD),^\[[@R15]\]^ and cancer.^\[[@R16],[@R17]\]^ However, other studies have found no evidence supporting this pattern.^\[[@R18],[@R19]\]^

The inconsistent patterns observed in the obesity--mortality association may be attributable to variations in the cutoff values for BMI categories used in different studies, or in race/ethnicity differences in the pattern of healthy obesity,^\[[@R20],[@R21]\]^ in addition to methodological differences such as source of BMI data (self-reported vs objective measures), residual confounding and/or selection bias. While the obesity paradox is observation of a protective effect in overweight and obese individuals, few studies have examined mortality outcomes in extreme BMI ranges among more severely obese populations, such as those with BMI \> 40 kg/m^2^. Few studies have examined higher ranges of BMI to determine health outcomes. Furthermore little is known about the relationship between obesity, particularly extreme obesity, and chronic disease outcomes particularly among hospitalized individuals. A limitation of prior studies is the lack of detailed data on other health conditions and comorbidities among patients that may strongly influence the obesity--mortality relationship. In addition, differences in baseline demographic characteristics, such as race/ethnicity, social and economic conditions, can contribute to differences in the association between obesity and disease outcomes.^\[[@R22]\]^ For instance, despite the similar low socioeconomic status (SES) of Hispanics and African Americans relative to Whites,^\[[@R23]\]^ and similar propensity for diabetes and obesity, Hispanics experience lower all-cause and cardiovascular mortality than African Americans and Whites.^\[[@R22],[@R24]\]^

Here, we studied the association between BMI and overall, cancer, COPD, asthma, and CVD-specific in-hospital outcomes in a large racial and socio-economically diverse study population, and determined whether race/ethnicity and SES differences remained after accounting for BMI.

2. Methods
==========

2.1. Study population
---------------------

Data for this analysis were obtained from the Health Cost and Utilization Project Nationwide Inpatient Sample (HCUP-NIS) inpatient database. The HCUP-NIS is a large all-payer inpatient care database on over 7 million hospitals stays and covers over 1000 hospitals in the United States.^\[[@R25]\]^ The database includes clinical variables on all diagnoses and procedures occurring during each hospital admission, and is widely considered the most valid and reliable source of epidemiological data on in-patient care and outcomes in the United States. Nonclinical variables are also included in the database, including median household income in the patient\'s zip code, rural/urban residence, and expected payment source. More information on HCUP-NIS can be obtained: <https://www.hcup-us.ahrq.gov/nisoverview.jsp>. All hospitalized patients ages 40 years and above diagnosed between 2007 and 2011 were included in this analysis. This study was considered institutional review board exempt as it involved analysis of de-identified, publicly available datasets.

2.2. Classifying BMI
--------------------

The BMI is a measure of body fat based on individual (both men and women) height and weight. It is calculated as a person\'s weight in kilograms (kg) divided by their height in meters squared (m^2^). The HCUP-NIS includes specific International Classification of Diseases---9th Revision (ICD-9) codes (V85.XX) for BMI in cases where such measures were obtained during hospital admission. The NIH categorizes BMI \< 18.5 as underweight, 18.5 to 24.9 as normal weight, 25 to 29.9 as overweight, and BMI of 30 or greater as obese. Since the purpose of this analysis was to determine the influence of body weight on hospitalization outcomes, we created a wide range of BMI categories: normal (BMI ≤ 24; ICD-9 V85.0--V85.1), preobesity (BMI 25--29; ICD-9 V85.21--V85.25), BMI 30 to 31.9 (ICD-9 V85.30--V85.31), BMI 32 to 33.9 (ICD-9 V85.32--V85.33), BMI 34 to 35.9 (ICD-9 V85.34--V85.35), BMI 36 to 37.9 (ICD-9 V85.36--V85.37), BMI 38 to 39.9 (ICD-9 V85.38--V85.39), BMI 40 to 49.9 (ICD-9 V85.41--V85.42), and BMI ≥ 50 (ICD-9 V85.43--V85.54).

2.3. Clinical variables
-----------------------

We examined the association between BMI categories and overall mortality, disease-specific mortality, postsurgical complications, and hospital length of stay (LOS-defined as number of days between admission and discharge, with single day admissions coded as 0) among patients admitted with a primary diagnosis of cancer (ICD-9: 140--209); COPD (ICD-9: 490, 491, 494, 496); asthma (ICD-9: 493); and CVD (ICD-9: 430--438). In addition, to account for comorbidities that may contribute to risk of mortality, we created a modified Deyo comorbidity index using ICD-9 codes.^\[[@R26]--[@R28]\]^ The conditions included diabetes mellitus with or without dementia, rheumatic disease, peptic ulcer disease, mild liver disease, hemiplegia or paraplegia, renal disease, moderate or severe liver disease, and HIV/AIDS. The presence of each condition within each patient was identified, and a single comorbidity score was created as the sum of the number of conditions per patient and was categorized as 0, 1, and ≥2.

2.4. Individual variables
-------------------------

Other covariates used in the analysis included: race/ethnicity (White, Black, Hispanic, and other), age, gender, residential income, insurance type, and residential region. Age was categorized into 40 to 50, 50 to 60, 60 to 70, and \>70 years; residential income was categorized into quartiles ranging from the lowest income to the highest income based on median household income at the zip code level; residential region was categorized into large metropolitan areas (metropolitan areas with 1 million residents or more, reference group), small metropolitan areas (metropolitan areas with \<1 million residents), and micropolitan areas (nonmetropolitan areas adjacent to metropolitan areas) using the 2003 version of the Urban Influence Codes.^\[[@R29]\]^ Insurance status was classified into Medicaid, Medicare, private (includes Blue Cross, commercial carriers, private health maintenance organizations and preferred provider organizations, and self-insured, reference group) and others (includes Worker\'s Compensation, Title V, and other government programs).

2.5. Statistical analysis
-------------------------

We conducted descriptive statistics to examine differences in the distribution of the 9 BMI categories by race/ethnicity and other sociodemographic variables using chi-squared tests and analysis of variance (for continuous variables). Logistic regression analysis was performed to determine the association between each BMI category and overall, cancer, COPD, asthma, and CVD-specific in-hospital mortality adjusting for race/ethnicity; age; gender; residential income; insurance type; residential region; and comorbidities. Multivariable linear regression models were used to examine the association between BMI categories and hospital LOS, and multivariable logistic regression models were used to examine postoperative complication outcomes. All statistical analyses were conducted in SAS 9.4.

3. Results
==========

This study included a total of 800,417 patients, 72% White, 16% Black, 8.4% Hispanic, and 4% other race (Table [1](#T1){ref-type="table"}). The distribution of BMI categories by other sociodemographic variables is presented in Table [2](#T2){ref-type="table"}. A higher proportion of other race (19.4%) and Whites (13.2%) were of normal weight (BMI 19--24) compared with Blacks (11.8%) and Hispanics (11.5%); and a higher proportion of other race (15.8%) and Hispanics (15.1%) were preobese (BMI 25--29.9) compared with Whites (12.3%) and Blacks (10.9%). However, a higher proportion of Blacks (26.8%; 12.5%) and Whites (23.3%; 8.7%) had BMI of 40 to 49.9 and ≥50, respectively, compared with Hispanics (20.4%; 7.3%) and other race (16.9%; 6.3%). Patients with normal BMI tended to have a higher mean age (71.5 years) at admission, and the mean age tended to decrease as BMI increased. There was a higher proportion of females in the higher BMI categories (BMI \> 36) compared with males, and the proportion of residents in high residential income areas tended to decline as BMI increased. A higher proportion of patients with normal BMI had 1 (10.6%) or ≥2 (1.9%) comorbid conditions, compared the highest BMI category with 1 (2.8%) or ≥2 (0.6%) comorbid conditions. Similarly, the proportion of patients with a primary diagnosis of cancer (6.0%), asthma (1.2%), and COPD (7.3%) was the highest among patients of normal weight, except patients with BMI 40 to 49.9, who had a higher prevalence of asthma (2.5%).
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Distribution of BMI categories by race/ethnicity, Nationwide Inpatient Sample 2007 to 2011.

![](medi-95-e4189-g001)

###### 

Socio-demographic characteristics by BMI categories, Nationwide Inpatient Sample 2007 to 2011.
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Figure [1](#F1){ref-type="fig"} shows the odds of in-hospital mortality in relation to increasing BMI, which appeared to follow a bell-shaped curve, increasing 3.6-fold (odds ratio \[OR\] 3.62, 95% confidence interval \[CI\]: 3.37--3.89) for preobese compared with normal BMI patients, 6.5-fold (OR: 6.52, 95% CI: 5.79--7.34) for patients with BMI: 30 to 31.9, 7.5-fold (OR: 7.57, 95% CI: 6.67--8.59) for patients with BMI: 34 to 35.9, 2.5-fold (OR: 2.59, 95% CI: 2.46--2.73) for patients with BMI 40 to 49.9, and 1.6-fold (OR: 1.77, 95% CI: 1.56--1.79) for patients with BMI ≥ 50. There were no racial differences in overall mortality after accounting for BMI and other study covariates, except for patients of other race who experienced significantly lower odds of mortality (OR: 0.88, 95% CI: 0.82--0.95) compared with Whites.
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There were clear trends of decreasing number of days spent in the hospital with increasing BMI and then an attenuation of effect in the highest BMI categories (Fig. [2](#F2){ref-type="fig"}). Preobese patients spent an average of 1.6 days less (β: −1.58, 95% CI: −1.63, −1.52) in the hospital compared with normal weight patients, while patients with BMI 30 to 39.9 spent an average of 2 days less in the hospital. Blacks (β: 0.38, 95% CI: 0.33, 0.43), Hispanics (β: 0.24, 95% CI: 0.18, 0.31), and other (β: 0.84, 95% CI: 0.76, 0.92) races experienced longer hospital stays compared with Whites as did females, patients residing in higher residential income areas and patients with at least 1 comorbid. Similar trends by BMI category were observed among cancer, COPD, asthma, and CVD patients. OR and estimates from multivariable adjusted analysis of in-hospital mortality and hospital LOS in relation to BMI are presented in Supplementary Tables 1 and 2.
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In multivariable adjusted analysis assessing medical complications overall (Table [3](#T3){ref-type="table"}), there were no clear trends across BMI categories, and preobese patients had slightly higher odds of complications (OR: 1.07, 95% CI 1.03--1.10) compared with normal weight patients, while patients with BMI 34 to 39.9 had about 9% lower odds of complications. In addition, Blacks, Hispanics, and females also experienced lower odds of complications, as well as patients residing in higher residential income areas and patients with at least 1 comorbid condition. Among cancer patients, there was a trend of increasing odds of complications with increasing BMI, ranging from 22% higher odds among the preobese to 63% higher odds among patients with BMI 40 to 49.9. Cancer patients with 1 or ≥2 comorbid condition also experienced 5- to 7-fold increased odds of complications (OR for 1 complication: 6.67, 95% CI: 5.60--7.95; OR for ≥2 complications: 5.28, 95% CI: 4.39--6.36). There were no trends by BMI among asthma patients; however, those with comorbidities experienced up to 11-fold increased odds of complications.
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Multivariable adjusted associations between BMI and complications.
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4. Discussion
=============

Using the HCUP Nationwide Inpatient database, we examined hospitalized patients with a wide-range of BMI values, and determined the association between BMI and overall, cancer, COPD, asthma, and CVD-specific mortality. We observed that 74.5% of hospitalized patients in this analysis had a BMI \> 30, and thus were obese; 32.5% of patients were morbidly obese (BMI \> 40 kg/m^2^); and Black patients were least likely to have BMI in the normal range, with 12.5% of Black patients having a BMI \> 50. In addition, we observed a striking bell-shaped relationship between BMI and overall, cancer, COPD, Asthma, and CVD-specific in-hospital mortality. Compared with those with normal BMI (BMI: 19.0--24.0 kg/m^2^), patients with BMI 25 to 29 experienced a 3.6-fold increase in odds of in-hospital mortality, increasing to 7.5-fold among those with BMI 34 to 35.9, then declining to 1.7-fold among those with BMI \> 50. Similar trends were observed for patients hospitalized with a primary diagnosis of cancer, COPD, asthma, and CVD, with the largest difference among asthma patients. In contrast, odds of complications increased significantly in a linear fashion with increasing BMI, but only among cancer patients, while a less pronounced but significant U-shaped pattern was observed for hospital LOS with increasing BMI. There were significant Black--White differences in in-hospital mortality but only for COPD and CVD, and while Black patients were less likely to experience complications for all examined conditions, they had significantly longer hospital stay across all conditions compared with Whites.

As we expected, the prevalence of overweight and obese among adults in the HCUP-NIS database was higher compared with national estimates. According to the 2011 National Health and Nutrition Examination Survey (NHANES), the national prevalence estimate of obesity was 34.9% in the general population of US adult\'s age ≥20 years.^\[[@R30]\]^ The prevalence of extreme obesity (BMI ≥ 40 kg/m^2^) was 6.4% overall, with a higher prevalence in women (8.3%) compared with men (4.4%), and the highest prevalence observed among non-Hispanic Black adults (12.1%).^\[[@R30]\]^ Since obesity is the most common risk factor across multiple chronic diseases, our results, while striking, were expected and in line with other studies of overweight and obesity among nonhealthy adults, mostly focused on adult outpatients, with prevalence rates of around 80%.^\[[@R31],[@R32]\]^ In extremely obese patients, the overrepresentation of younger, Black, and female patients corresponds to estimates reported in NHANES study, and provides further evidence that these trends are important contributors to worsening race and sex disparities in outcomes of multiple chronic diseases, such as COPD and cancer.^\[[@R33],[@R34]\]^

In the general population, overweight and obesity are well-known risk factors for several chronic diseases and all-cause mortality. However, among elderly or diseased individuals, the relationship between body weight and mortality has been the subject of some debate. Janssen and Mark^\[[@R35]\]^ performed a meta-analysis examining the association between elevated BMI and all-cause mortality in the elderly, and reported that overweight was not associated with a significantly increased risk of mortality, while moderate obesity was associated with a modest increase in risk. In contrast, another meta-analysis by Flegal et al^\[[@R36]\]^ evaluating the associations of overweight and obesity with all-cause mortality in the elderly showed that overall obesity was associated with significantly higher all-cause mortality, although the association varied depending on BMI.^\[[@R2]\]^ Mixed results have also been reported in studies that examined the association between obesity and mortality among participants with cancer,^\[[@R37]\]^ COPD,^\[[@R15],[@R38],[@R39]\]^ asthma, and CVD.^\[[@R7],[@R11]\]^

We observed modest associations between BMI categories and complications, except for cancer patients. The relationships between obesity and clinical outcomes have been explored in among adults with severe illness, across various disciplines. Overall, results are conflicting: some studies reported increase association between obesity and complications,^\[[@R40]--[@R47]\]^ while other studies did not observe significant associations.^\[[@R48]--[@R51]\]^ This suggests that for some chronic diseases, higher BMI may not necessarily translate to more invasive treatment modalities, which are often the proximal causes of complications. Based on the findings of various large-scale studies,^\[[@R52]--[@R54]\]^ it is plausible to presume that obese patients who would have longer hospital stays through increased prevalence of comorbidities, complications, and longer recovery. Yet, we observed that patients with higher BMI had shorter hospital stays compared with patients with normal BMI. This trend was consistent across all conditions, and observed even after adjusting for number of comorbidities. This suggests that when differences in comorbid conditions are accounted for, patients with higher BMI tended to be discharged sooner. Hauck and Hollingsworth examined the hospital data for 122 Australian public hospitals during the year 2005/2006 (Victorian Admitted Episodes Data),^\[[@R52]\]^ and observed that surgically managed obese patients spent less time in the hospital (−0.3 day, *P* = 0.029). The authors suggested that hospitals may shorten the LOS for obese surgical patients by transferring them to another hospital or recovery facilities after surgery. Further studies may focus on assessing whether higher BMI patients were more likely to be discharged to skilled nursing facilities, to hospice care, or to their homes. If patients at the highest extremes of BMI are more likely to be discharged to hospice care, for instance, then health events such as mortality occurring after discharge will be under-estimated in hospital-based studies as those typically only captures in-hospital events. This is a potential limitation of the current analysis that may be further examined in longitudinal studies of patients.

Other possible reasons for conflicting results in prior studies might include multiple sources of methodological bias. First, different BMI cut-points are often used in different studies. In some studies, higher BMI categories are collapsed to delineate more severe degrees of obesity (i.e., only ≥30 kg/m^2^), and most studies show worse prognosis in the group with BMI \> 35 kg/m^2^.^\[[@R1]\]^ For example, a recent pooled analysis of 20 prospective studies found BMI of 40 to 59 kg/m^2^ was associated with substantially elevated rates of total mortality, with most of the excess deaths due to heart disease, cancer, and diabetes, compared with normal weight.^\[[@R55]\]^ Conversely, some studies include the underweight BMI category (18.5--24.9 kg/m^2^) as a reference group, seriously underestimating the BMI--mortality association by creating an artifact of reduced mortality among the overweight and moderately obese groups. This is likely because the underweight BMI category contains not only individuals who are lean and active but also heavy smokers, the frail and elderly, and those who are ill with previous weight loss or diminished weight gain due to existing diseases.

Another methodological limitation of some prior studies is the source of BMI data. Self-reported height and weight are the least reliable sources of epidemiologic data, subject to significant bias, which may be differential in relation to disease status. Furthermore, among adult inpatients, previous studies have reported that BMI calculations are seldom performed during hospitalization, and that overweight/obesity is rarely included among discharge diagnoses documentation,^\[[@R56],[@R57]\]^ raising questions about differential misclassification in whose BMI gets recorded and/or included in administrative databases. By assessing a wide range of BMI values with smaller categorical cut-points, using claims-based ICD-9 codes for BMI categories, and assessing outcomes only among patients with a BMI coding, this analysis aimed to address some of these limitations.

The specific biological mechanisms linking obesity and clinical outcomes have not been entirely elucidated. One possible explanation of the negative effect of obesity may be accounted for by malnutrition. While obesity involves excess caloric intake, several studies have shown a high prevalence of micronutrient deficiencies in obese patients across a broad range of both vitamins and minerals.^\[[@R58]\]^ Alternatively, it is possible that BMI is a poor measure of body fat due to the positive correlation between BMI and muscle mass, while lean muscle mass has been shown to exert protective effects on cardiometabolic diseases such as CVD and cancer. Studies among COPD^\[[@R59]\]^ and cancer^\[[@R60]\]^ patients have demonstrated that overweight or obese patients are at increased risk for malnutrition, which contributes to poor outcomes. Malnourished patients have slower healing, more complications, increased LOS, increased hospital costs, and greater mortality.^\[[@R61]\]^ Severely obese patients are also medically more complex in part due to an increased burden of pre-existing illness (comorbidities and acute illness), delayed wound healing and undiagnosed or under-diagnosed conditions such as asthma and COPD. Both asthma and COPD are major chronic obstructive airway diseases that involve airway inflammation, and the coexistence of both conditions in obese patients has been reported,^\[[@R62]\]^ in some studies exceeding half of the patients examined.^\[[@R63],[@R64]\]^ These conditions are also associated with severe morbidity and mortality.^\[[@R65]\]^ Other major health conditions, such as nonalcoholic fatty liver disease, have also been strongly linked with overweight/obesity and diabetes,^\[[@R66]\]^ and in turn may be associated with increased risk of other systemic chronic diseases such as CVD^\[[@R67]\]^ and cancer,^\[[@R68]\]^ further highlighting the multifactorial role of overweight/obesity on negative health outcomes in adults.

In conclusion, the majority of US hospitalized patients are either overweight or obese, and higher levels of obesity are associated with significantly higher risk of mortality and length of hospital stay. The observed attenuation of the association between higher BMI categories and mortality may be due to early discharge of obese patients to external facilities prior to death.
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